Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-03 Sale |
2024-01-05 7:58 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel |
33,190 | $34.36 | $1,140,362 | 464,385 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 5:25 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
9,952 | $31.01 | $308,637 | 3,715,048 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-22 5:04 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
12,000 | $28.54 | $342,480 | 3,725,000 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-22 2:31 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer |
19,700 | $28.8 | $567,315 | 131,800 (Direct) |
View |
| 2023-10-25 Sale |
2023-10-27 6:23 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
24,338 | $24.21 | $589,223 | 3,737,000 (Direct) |
View |
| 2023-09-28 Sale |
2023-10-02 5:51 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director |
1,550 | $26.33 | $40,812 | 21,734 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 6:10 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
57,755 | $28.12 | $1,624,223 | 4,170,563 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 6:04 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer |
8,925 | $35.31 | $315,142 | 61,575 (Direct) |
View |
| 2023-06-30 Sale |
2023-07-05 6:15 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine |
3,000 | $35.53 | $106,590 | 188,484 (Direct) |
View |
| 2023-06-27 Sale |
2023-06-29 6:41 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
15,000 | $36.2 | $543,000 | 381,704 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-08 6:29 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
6,500 | $40.9 | $265,850 | 143,135 (Indirect Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 7:04 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
104,928 | $39.32 | $4,125,674 | 4,745,298 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 6:04 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
11,350 | $32.65 | $370,578 | 7,867 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 6:14 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
875 | $32.62 | $28,542 | 149,635 (Indirect Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 8:35 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director |
1,764 | $0 | $0 | 27,877 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 8:23 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
3,200 | $30 | $96,000 | 41,410 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 7:30 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel |
15,000 | $37.39 | $560,850 | 413,375 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 7:24 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine |
13,803 | $37.4 | $516,232 | 191,484 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 7:10 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel |
17,500 | $38.33 | $670,802 | 428,375 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 7:05 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine |
10,338 | $38.38 | $396,738 | 205,287 (Direct) |
View |
| 2022-12-29 Sale |
2022-12-30 5:12 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
30,625 | $40 | $1,225,000 | 336,704 (Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 6:05 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer |
19,500 | $29.99 | $584,738 | 91,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-04 Option Award |
2024-01-05 7:58 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel |
85,000 | $0 | 464,385 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 4:03 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director |
14,987 | $25.41 | 65,825 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 3:55 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
14,987 | $25.41 | 114,754 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 3:54 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
14,987 | $25.41 | 22,854 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 3:52 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director |
14,987 | $25.41 | 36,721 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 3:51 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
14,987 | $25.41 | 132,622 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 3:41 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
14,987 | $25.41 | 51,804 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-20 6:10 pm |
2013-10-01 2023-09-21 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
57,555 | $0 | 4,170,563 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-20 6:10 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
57,755 | $4.75 | 4,170,563 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-05 7:04 pm |
2013-06-01 2023-05-06 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
104,928 | $0 | 4,745,298 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-05 7:04 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
104,928 | $2.01 | 4,745,298 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-12 3:23 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director |
12,460 | $0 | 55,431 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:38 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director |
12,460 | $0 | 35,860 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:35 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director |
12,460 | $0 | 27,877 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:32 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
12,460 | $0 | 104,360 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:27 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
12,460 | $0 | 128,728 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:23 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
12,460 | $0 | 41,410 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 8:17 pm |
2024-01-10 2033-01-10 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
12,460 | $0 | 23,810 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 7:21 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer |
500 | $0 | 70,500 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 7:18 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer |
60,000 | $0 | 151,500 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 7:14 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
60,000 | $0 | 396,704 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 7:10 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel |
65,000 | $0 | 428,375 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 7:05 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine |
60,000 | $0 | 205,287 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-22 8:01 pm |
2016-02-01 2026-01-01 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
32,000 | $0 | 380,875 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-22 8:01 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
32,000 | $6.15 | 380,875 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:09 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
252,400 | $0 | 3,720,714 (Direct) |
View |
| 2022-06-15 Ownership |
2022-09-30 5:32 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
96,676 | $0 | 367,329 (Direct) |
View |
| 2022-09-27 Exercise |
2022-09-29 5:15 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
39,082 | $30.77 | 3,468,314 (Direct) |
View |
| 2022-09-27 Exercise |
2022-09-29 5:15 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
1,542 | $31.21 | 3,468,314 (Direct) |
View |